Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

Intermittent fasting could help protect the brain from age-related diseases like Alzheimer's

As the world population has grown older, Alzheimer’s disease has become increasingly common. Alzheimer’s disease is the most prevalent form of dementia. Dementia is a term used to describe a range of symptoms linked to the decline in brain function with age. Symptoms include memory loss, communication difficulties, problem-solving struggles,…

The Conversation

3 Stocks to Own as Alzheimer's Drugs Bring Relief

The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…

StockNews.com

Are you at risk of developing Alzheimer's Disease? A simple screener can tell—and so can these 11 early warning signs

A quick test that mimics real-life phone tasks can tell if a senior is at risk for Alzheimer’s disease, according to a new study.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

LOCALIZE IT: From birth to death, Black Americans struggle with health care system

EDITORS/NEWS DIRECTORS:

The Independent UK

All you need to know about weight-loss drug Wegovy and Ozempic tipped to treat dementia

Although age is by far the greatest risk factor for dementia, obesity and type 2 diabetes are also major risk factors

Wales Online

Wegovy and Ozempic: could the new weight-loss drug also treat dementia?

Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new weight-loss jab, Wegovy.

The Conversation

Scientists make Alzheimer's breakthrough thanks to man who could hold cure in his genes

Rare genetic resilience to the disease has been identified in a second patient

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Scientists Discover New Genetic Variants That Protect Against Alzheimer’s Disease

In a new study, researchers identified a rare gene mutation that may offer resiliency against Alzheimer's disease.

Inverse

Researchers identify rare genetic resilience to Alzheimer’s disease – study

Researchers suggest the findings could open a door for the prevention and treatment of incurable diseases.

The Independent UK

Study reveals traffic-related air pollution affects brain function

According to a study from the University of California, Irvine, exposure to traffic-related air pollution causes memory loss, cognitive decline, and the activation of brain pathways linked to the onset of Alzheimer's disease. Read further on Dynamite News:

Dynamite News

All you need to know about 'promising' new Alzheimer's drug

Donanemab was shown in a late-stage trial to slow cognitive decline more than a third

Wales Online

New Alzheimer’s drug: what you need to know about donanemab’s promising trial results

American pharmaceutical company Eli Lilly announced last week that it had seen encouraging clinical trial results of its new Alzheimer’s medication. According to the company, their experimental drug, donanemab, was shown in a late-stage trial to slow cognitive decline by 35%. While these results do sound promising, the full data…

The Conversation

World ‘on cusp of first generation of treatments for Alzheimer’s’

Almost half of those on donanemab had no clinical progression of disease at one year compared with 29% on a placebo, a study showed.

Evening Standard

World ‘on the cusp of first generation of treatments for Alzheimer’s’

THE world is “on the cusp of a first generation of treatments for Alzheimer’s disease”, experts have said, as a new drug was found to slow…

The National (Scotland)

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

World ‘on cusp of first generation of treatments for Alzheimer’s’ as new drug ‘slows symptoms’

New drug donanemab appears to slow decline associated with Alzheimer’s

The Independent UK

World ‘on cusp of first generation of treatments for Alzheimer’s’ as new drug found

Almost half of those on donanemab had no clinical progression of disease at one year compared to 29% on placebo, a study showed.

The Street

Eli Lilly Surges On Promising Data From Late-Stage Alzheimer's Drug Trial

"This is the first Phase 3 trial of any investigational medicine for Alzheimer's disease to deliver 35% slowing of clinical and functional decline," Eli Lilly said.

The National (Scotland)

It's time for us all to talk about dementia – which is so much more than forgetting

MY mother asks me frequently: “Where am I? What is this place?” She cranes her neck to look out of a window as if the view – newly revealed…

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Record

Alzheimer's symptoms as study finds common pill could reduce risk of disease

Scientists discovered that people who popped the drugs before bedtime had fewer rogue brain proteins linked to the disease.

Wales Online

The stunningly heartbreaking Alzheimer’s Society ad that has people in tears

The short film, titled 'The Ultimate Vow', shows how an elderly couple have been affected by Alzheimer's disease

Dynamite News

Early menopause without Hormone therapy could risk Alzheimer's disease: Study

Women are more likely than men to develop Alzheimer's disease (AD), with women making up two-thirds of the population living with AD. Read further on Dynamite Nes:

The Independent UK

‘Starting hormone therapy at menopause onset does not increase Alzheimer’s risk’

Women are more likely than men to develop Alzheimer’s disease, researchers say.

The Japan News/Yomiuri

Clinical tests to begin on drugs for familial Alzheimer's disease

A team of researchers from Niigata University and the University of Tokyo will begin clinical tests this year of medicines to treat people with familial Alzheimer's disease.

The Orange County Register

Alzheimer’s report hints at a future health crisis bigger than COVID-19

The costs of Alzheimer’s disease – human and financial – are rising sharply in California and nationally, and census projections for America’s rapidly aging population suggest the scope of the disease soon might rival what America saw during the height of the COVID-19 pandemic.

The Conversation

Alzheimer’s disease: problems with the brain’s energy supply could be a cause

Scientists have been working to understand the root causes of dementia and Alzheimer’s disease for decades now. But one of the reasons we don’t yet have a cure for this disease is because of the complexity of the human brain – alongside the complexity of the disease itself.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

the Food and Drug Administration

Queen Mary University of London

67 stories

Massachusetts General Hospital

46 stories

the Alzheimer Society

37 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.